Skip to main content
URMC / Labs / Gelbard Lab / Publications, Patents, and Publicity


Publications, Patents, and Publicity



  1. Chemical preconditioning as a preventative or treatment for excitotoxic synaptic damage. US Provisional Patent Application No. 60/731,742. International Patent Application No. PCT/US2006/042213.  Inventors: M.J. Bellizzi, S.-M. Lu, H.A. Gelbard.
  2. Treatment of NeuroAIDS using inhibitors of glycogen synthase kinase (GSK)-3. US Provisional Patent Application No. 60/753,614. International Patent Application No. PCT/US2006/009390.  Inventors: H.A. Gelbard, S.B. Maggirwar, S. Dewhurst.
  3. MLK inhibitors and methods of use. Composition of matter, attorney docket: URMC0001-101-US. International Patent Application No. PCT/065878 Inventors: H.A. Gelbard, S. Dewhurst, VS Goodfellow, T. Wiemann.


Jamie Talan. Thinking could be harmful to people with brain diseases. Newsday, February 3, 2006

Jamie Talan. Stopping HIV dementia. Scientific American Mind, August 2006.

Scott P. Edwards. The other side of cytokines. The Dana Foundation News and Periodicals, September 1, 2006

Lauran Neergard. Surviving AIDS can wreak havoc on the brain – Associated Press, October 2, 2006

Chael Needle Brain Matter: Researchers look to adjunctive therapies to treat NeuroAIDS. A&U, November 2006, pp. 34-35

Laura Whitehorn and Rebecca Minnich. Dazed and Confused. POZ, April 2007, pp. 33-34.

Jamie Talan. Valproic acid is neuroprotective in a mouse model of Alzheimer’s disease. Neurology Today 18 December 2008 - Volume 8 - Issue 24 - p 17-18doi: 10.1097/01.NT.0000343222.76902.59

Elizabeth Norton Lasley. Researchers find new point of entry for HIV in brain cells. The Dana Foundation News and Periodicals January 5, 2009

Tom Rickey. Researchers target HIV-related brain difficulties.  URMC Newsroom: October 7, 2010